220 related articles for article (PubMed ID: 18752332)
1. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
Yeoman AD; Al-Chalabi T; Karani JB; Quaglia A; Devlin J; Mieli-Vergani G; Bomford A; O'Grady JG; Harrison PM; Heneghan MA
Hepatology; 2008 Sep; 48(3):863-70. PubMed ID: 18752332
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma and survival in patients with autoimmune hepatitis (Japanese National Hospital Organization-autoimmune hepatitis prospective study).
Migita K; Watanabe Y; Jiuchi Y; Nakamura Y; Saito A; Yagura M; Ohta H; Shimada M; Mita E; Hijioka T; Yamashita H; Takezaki E; Muro T; Sakai H; Nakamuta M; Abiru S; Komori A; Ito M; Yatsuhashi H; Nakamura M; Ishibashi H;
Liver Int; 2012 May; 32(5):837-44. PubMed ID: 22221966
[TBL] [Abstract][Full Text] [Related]
3. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
5. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States.
Davila JA; Henderson L; Kramer JR; Kanwal F; Richardson PA; Duan Z; El-Serag HB
Ann Intern Med; 2011 Jan; 154(2):85-93. PubMed ID: 21242365
[TBL] [Abstract][Full Text] [Related]
6. Annual incidence of hepatocellular carcinoma among patients with alcoholic cirrhosis and identification of risk groups.
Mancebo A; González-Diéguez ML; Cadahía V; Varela M; Pérez R; Navascués CA; Sotorríos NG; Martínez M; Rodrigo L; Rodríguez M
Clin Gastroenterol Hepatol; 2013 Jan; 11(1):95-101. PubMed ID: 22982095
[TBL] [Abstract][Full Text] [Related]
7. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in primary biliary cirrhosis and its impact on outcomes.
Jones DE; Metcalf JV; Collier JD; Bassendine MF; James OF
Hepatology; 1997 Nov; 26(5):1138-42. PubMed ID: 9362353
[TBL] [Abstract][Full Text] [Related]
9. Predictive score for the development of hepatocellular carcinoma and additional value of liver large cell dysplasia in Western patients with cirrhosis.
Ganne-Carrié N; Chastang C; Chapel F; Munz C; Pateron D; Sibony M; Dény P; Trinchet JC; Callard P; Guettier C; Beaugrand M
Hepatology; 1996 May; 23(5):1112-8. PubMed ID: 8621142
[TBL] [Abstract][Full Text] [Related]
10. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
[TBL] [Abstract][Full Text] [Related]
12. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series.
Wong RJ; Gish R; Frederick T; Bzowej N; Frenette C
Dig Dis Sci; 2011 Feb; 56(2):578-85. PubMed ID: 21046244
[TBL] [Abstract][Full Text] [Related]
13. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
14. Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
Dakhoul L; Jones KR; Gawrieh S; Ghabril M; McShane C; Vuppalanchi R; Vilar-Gomez E; Nephew L; Chalasani N; Lammert C
Dig Dis Sci; 2019 Jun; 64(6):1705-1710. PubMed ID: 30617453
[TBL] [Abstract][Full Text] [Related]
15. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
[TBL] [Abstract][Full Text] [Related]
16. Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
Silveira MG; Suzuki A; Lindor KD
Hepatology; 2008 Oct; 48(4):1149-56. PubMed ID: 18785621
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for hepatocellular carcinoma in patients with liver cirrhosis.
Macías Rodríguez MA; Rendón Unceta P; Tejada Cabrera M; Infante Hernández JM; Correro Aguilar F; Díaz García F; Benítez Rodríguez E; Mangas Rojas A; Martín Herrera L
Rev Esp Enferm Dig; 2000 Jul; 92(7):458-69. PubMed ID: 11026763
[TBL] [Abstract][Full Text] [Related]
18. Hepatocellular carcinoma associated with autoimmune hepatitis.
Nishiyama R; Kanai T; Abe J; Hara R; Watahiki Y; Sakaguchi T; Nakamura S
J Hepatobiliary Pancreat Surg; 2004; 11(3):215-9. PubMed ID: 15235898
[TBL] [Abstract][Full Text] [Related]
19. Screening for hepatocellular carcinoma in patients with cirrhosis in the United States: results of a national survey.
Chalasani N; Said A; Ness R; Hoen H; Lumeng L
Am J Gastroenterol; 1999 Aug; 94(8):2224-9. PubMed ID: 10445554
[TBL] [Abstract][Full Text] [Related]
20. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
Yuen MF; Tanaka Y; Fong DY; Fung J; Wong DK; Yuen JC; But DY; Chan AO; Wong BC; Mizokami M; Lai CL
J Hepatol; 2009 Jan; 50(1):80-8. PubMed ID: 18977053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]